World's Best Scientists 2026 revealed!
Fabio Piscaglia

Fabio Piscaglia

D-Index & Metrics

Medicine

D-Index
98
Citations
58256
World Ranking
8738
National Ranking
295

Fabio Piscaglia publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Fabio Piscaglia sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 606 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Fabio Piscaglia D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Fabio Piscaglia sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 98 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Fabio Piscaglia is affiliated with the University of Bologna in Italy and has a research focus primarily within the field of Medicine, with a strong specialization in Hepatology. Their publication record includes 701 works in Medicine, of which 236 are specifically related to Hepatology, followed by contributions to Epidemiology (126), Oncology (91), Surgery (52), and Pulmonary and Respiratory Medicine (45).

The scientist's research covers several significant topics, including hepatocellular carcinoma treatment and prognosis, liver disease diagnosis and treatment, and liver disease and transplantation. Other areas of focus include colorectal cancer studies, cholangiocarcinoma and gallbladder cancer, hepatitis C virus research, and cancer mechanisms and therapy.

Fabio Piscaglia's frequent co-authors include:

  • Francesco Tovoli
  • Bernardo Stefanini
  • Giuseppe Cabibbo
  • Alessandro Granito
  • Gianluca Masi

The scientist has published extensively in a select group of journals, with the highest number of works appearing in:

  • Digestive and Liver Disease (53 publications)
  • Journal of Hepatology (38 publications)
  • Ultraschall in der Medizin - European Journal of Ultrasound (14 publications)
  • Cancers (11 publications)
  • Liver International (9 publications)

Key recent publications by Fabio Piscaglia include:

  • Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS, 2020, Ultrasound in Medicine & Biology
  • Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial, 2023, The Lancet Oncology
  • Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver - Update 2020 - WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS, 2020, Ultraschall in der Medizin - European Journal of Ultrasound
  • Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept, 2023, The Lancet Oncology
  • Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database, 2021, Gut

Best Publications

  • EASL-EORTC clinical practice guidelines : management of hepatocellular carcinoma

    Peter R. Galle;Alejandro Forner;Josep M. Llovet;Vincenzo Mazzaferro

  • Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

    Masatoshi Kudo;Richard S. Finn;Shukui Qin;Kwang Hyub Han

  • EFSUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography. Part 1: Basic Principles and Technology

    J Bamber;D Cosgrove;C. F Dietrich;J Fromageau

  • The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): Update 2011 on non-hepatic applications

    F Piscaglia;C Nolsøe;C F Dietrich;D O Cosgrove

  • Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.

    Michel Claudon;Christoph F. Dietrich;Byung Ihn Choi;David O. Cosgrove

  • Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver - Update 2012

    M. Claudon;C. F. Dietrich;B. I. Choi;D. O. Cosgrove

  • EFSUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography.Part 2: Clinical Applications

    D Cosgrove;F Piscaglia;J Bamber;J Bojunga

  • Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - Update 2008

    M. Claudon;D. Cosgrove;T. Albrecht;L. Bolondi

  • EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)

    Christoph F Dietrich;Jeffrey Bamber;Annalisa Berzigotti;Simona Bota

  • The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version)

    Paul S. Sidhu;Vito Cantisani;Christoph F. Dietrich;Odd Helge Gilja

  • Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis

    L Bolondi;S Sofia;S Siringo;S Gaiani

  • Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions.

    Luigi Bolondi;Andrew Burroughs;Jean François Dufour;Peterr R. Galle

  • The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations.

    Fabio Piscaglia;Luigi Bolondi

  • Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization

    J.-L. Raoul;B. Sangro;A. Forner;V. Mazzaferro

  • Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

    Fabio Piscaglia;Gianluca Svegliati‐Baroni;Andrea Barchetti;Anna Pecorelli

  • Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS.

    Christoph F Dietrich;Christian Pállson Nolsøe;Richard G Barr;Annalisa Berzigotti

  • Characterization of small nodules in cirrhosis by assessment of vascularity: The problem of hypovascular hepatocellular carcinoma

    Luigi Bolondi;Stefano Gaiani;Natascia Celli;Rita Golfieri

  • Liver Transplantation for Hepatocellular Carcinoma: Results of Down‐Staging in Patients Initially Outside the Milan Selection Criteria

    M. Ravaioli;G. L. Grazi;F. Piscaglia;F. Trevisani

  • Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma

    Alessandro Cucchetti;Fabio Piscaglia;Matteo Cescon;Antonio Colecchia

  • Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy.

    Massimo Iavarone;Giuseppe Cabibbo;Fabio Piscaglia;Claudio Zavaglia

Frequent Co-Authors

Luigi Bolondi
Luigi Bolondi University of Bologna
Antonio Daniele Pinna
Antonio Daniele Pinna University of Bologna
Christoph F. Dietrich
Christoph F. Dietrich Hirslanden Private Hospital Group
Fabio Farinati
Fabio Farinati University of Padua
Masatoshi Kudo
Masatoshi Kudo Kindai University
Gian Luca Grazi
Gian Luca Grazi University of Bologna
Antonio Gasbarrini
Antonio Gasbarrini Catholic University of the Sacred Heart
Markus Peck-Radosavljevic
Markus Peck-Radosavljevic Klinikum Klagenfurt
Marco Valgimigli
Marco Valgimigli University of Bern
Gabriele Missale
Gabriele Missale University of Parma

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA opens up diverse pathways beyond traditional medical school. For those seeking a quicker route into healthcare, fast track lpn programs provide a streamlined option to become a Licensed Practical Nurse in less time, making it easier to start gaining clinical experience.

Many professionals also choose to advance their nursing careers online. Programs like online msn pmhnp programs allow registered nurses to specialize in psychiatric mental health, offering flexible learning options while meeting a growing industry demand.

For individuals interested in the business and leadership side of healthcare, healthcare administration degrees online offer a strong foundation in managing healthcare systems. Those seeking advanced roles may consider affordable online mha programs, which provide a cost-effective path to a master's degree in health administration.

Each of these online degree pathways can open doors to rewarding career prospects in healthcare—whether you aim to work directly with patients or lead from behind the scenes.

Best Scientists Citing Fabio Piscaglia

Trending Scientists

Recently Published Articles